Vu LP - Search Results

1

m⁶A RNA modifications: Key regulators of normal and malignant hematopoiesis.

Sommerkamp P, Brown JA, Haltalli MLR, Mercier FE, Vu LP, Kranc KR. Sommerkamp P, et al. Among authors: vu lp. Exp Hematol. 2022 Jul;111:25-31. doi: 10.1016/j.exphem.2022.04.006. Epub 2022 Apr 27. Exp Hematol. 2022. PMID: 35487293 Review.

2

Combinatorial assembly, traceless generation and in situ evaluation of inhibitors for therapeutically relevant serine proteases.

Vu LP, Zyulina M, Hingst A, Schnakenburg G, Gütschow M. Vu LP, et al. Bioorg Chem. 2022 Apr;121:105676. doi: 10.1016/j.bioorg.2022.105676. Epub 2022 Feb 11. Bioorg Chem. 2022. PMID: 35202850

3

Diketomorpholines: Synthetic Accessibility and Utilization.

Vu LP, Gütschow M. Vu LP, et al. ACS Omega. 2021 Dec 22;7(1):48-54. doi: 10.1021/acsomega.1c05964. eCollection 2022 Jan 11. ACS Omega. 2021. PMID: 35036677 Free PMC article. Review.

4

Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.

Prieto C, Nguyen DTT, Liu Z, Wheat J, Perez A, Gourkanti S, Chou T, Barin E, Velleca A, Rohwetter T, Chow A, Taggart J, Savino AM, Hoskova K, Dhodapkar M, Schurer A, Barlowe TS, Vu LP, Leslie C, Steidl U, Rabadan R, Kharas MG. Prieto C, et al. Among authors: vu lp. Nat Cancer. 2021 Jul;2:741-757. doi: 10.1038/s43018-021-00220-w. Epub 2021 Jul 5. Nat Cancer. 2021. PMID: 34458856 Free PMC article.

5

Introductions to the Community: Early-Career Researchers in the Time of COVID-19.

Takayama K, Weaver LN, Lummertz da Rocha E, Lo Sardo V, Gehart H, Vu LP. Takayama K, et al. Among authors: vu lp. Cell Stem Cell. 2020 Dec 3;27(6):853-855. doi: 10.1016/j.stem.2020.11.011. Cell Stem Cell. 2020. PMID: 33275897 Free PMC article.

6

Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders.

Steinebach C, Ng YLD, Sosič I, Lee CS, Chen S, Lindner S, Vu LP, Bricelj A, Haschemi R, Monschke M, Steinwarz E, Wagner KG, Bendas G, Luo J, Gütschow M, Krönke J. Steinebach C, et al. Among authors: vu lp. Chem Sci. 2020 Mar 4;11(13):3474-3486. doi: 10.1039/d0sc00167h. eCollection 2020 Apr 7. Chem Sci. 2020. PMID: 33133483 Free PMC article.

7

HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells.

Nguyen DTT, Lu Y, Chu KL, Yang X, Park SM, Choo ZN, Chin CR, Prieto C, Schurer A, Barin E, Savino AM, Gourkanti S, Patel P, Vu LP, Leslie CS, Kharas MG. Nguyen DTT, et al. Among authors: vu lp. Nat Commun. 2020 Apr 24;11(1):2026. doi: 10.1038/s41467-020-15814-8. Nat Commun. 2020. PMID: 32332729 Free PMC article.

8

m⁶A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment.

Cheng Y, Luo H, Izzo F, Pickering BF, Nguyen D, Myers R, Schurer A, Gourkanti S, Brüning JC, Vu LP, Jaffrey SR, Landau DA, Kharas MG. Cheng Y, et al. Among authors: vu lp. Cell Rep. 2019 Aug 13;28(7):1703-1716.e6. doi: 10.1016/j.celrep.2019.07.032. Cell Rep. 2019. PMID: 31412241 Free PMC article.

9

PROTAC-mediated crosstalk between E3 ligases.

Steinebach C , Kehm H , Lindner S , Vu LP , Köpff S , López Mármol Á , Weiler C , Wagner KG , Reichenzeller M , Krönke J , Gütschow M . Steinebach C , et al. Among authors: vu lp. Chem Commun (Camb). 2019 Feb 5;55(12):1821-1824. doi: 10.1039/c8cc09541h. Chem Commun (Camb). 2019. PMID: 30672516

10

The Biology of m⁶A RNA Methylation in Normal and Malignant Hematopoiesis.

Vu LP, Cheng Y, Kharas MG. Vu LP, et al. Cancer Discov. 2019 Jan;9(1):25-33. doi: 10.1158/2159-8290.CD-18-0959. Epub 2018 Dec 21. Cancer Discov. 2019. PMID: 30578356 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results